ROsuvastatin LOading and Clinical Outcomes Trial

Mise à jour : Il y a 4 ans
Référence : NCT01936805

Femme et Homme

  • | Pays :
  • Turkey
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The aim of the present study was to evaluate the effect of pre-procedural single high loading dose (40 mg) of rosuvastatin on the primary end-points of all cause mortality and composite of death or myocardial infarction from cardiovascular (CV) causes, target vessel revascularization (TVR), or stroke.


Critère d'inclusion

  • Atherosclerosis

Liens